Elevance Health (ELV) Liabilities and Shareholders Equity (2009 - 2026)

Elevance Health (ELV) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $126.4 billion in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 3.69% year-over-year to $126.4 billion in Q2 2026; TTM through Jun 2026 was $496.5 billion, a 4.51% increase from a year earlier, with the FY2025 full-year figure at $121.5 billion, up 3.94% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $126.4 billion, roughly flat from $125.8 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for ELV reached as high as $126.4 billion in Q2 2026 and fell as low as -$17.0 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $107.7 billion across 5 years, with a median of $112.4 billion in 2024.
• Across the five-year window, Liabilities and Shareholders Equity plunged 325.0% in 2022 and surged 640852.94% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at -$17.0 million in 2022, then jumped by 640852.94% to $108.9 billion in 2023, then rose by 7.31% to $116.9 billion in 2024, then gained by 3.94% to $121.5 billion in 2025, then increased by 4.07% to $126.4 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $126.4 billion in Q2 2026, $125.8 billion in Q1 2026, and $121.5 billion in Q4 2025.